Raymond James & Associates’s Morgan Stanley Emerging Mkts Fd MSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-77,755
Closed -$1.25M 3766
2018
Q4
$1.25M Sell
77,755
-4,951
-6% -$80.6K ﹤0.01% 1960
2018
Q3
$1.29M Buy
82,706
+2,738
+3% +$43.8K ﹤0.01% 2077
2018
Q2
$1.3M Buy
79,968
+23,875
+43% +$412K ﹤0.01% 2021
2018
Q1
$1.03M Buy
56,093
+12,801
+30% +$240K ﹤0.01% 2109
2017
Q4
$774K Buy
43,292
+4,135
+11% +$72.5K ﹤0.01% 2265
2017
Q3
$681K Buy
39,157
+10,172
+35% +$173K ﹤0.01% 2305
2017
Q2
$468K Buy
28,985
+14,273
+97% +$225K ﹤0.01% 2459
2017
Q1
$217K Buy
14,712
+3,950
+37% +$55.8K ﹤0.01% 2891
2016
Q4
$142K Sell
10,762
-427
-4% -$5.86K ﹤0.01% 2971
2016
Q3
$163K Buy
11,189
+10
+0.1% +$142 ﹤0.01% 2908
2016
Q2
$148K Sell
11,179
-4,113
-27% -$53.9K ﹤0.01% 2738
2016
Q1
$202K Buy
+15,292
New +$185K ﹤0.01% 2570
2015
Q3
Sell
-14,637
Closed -$217K 2426
2015
Q2
$217K Buy
+14,637
New +$224K ﹤0.01% 2360

Other funds holding MSF

Raymond James & Associates's MSF Position: Q1 2019 in Review

Raymond James & Associates sold out of Morgan Stanley Emerging Mkts Fd (MSF) in Q1 2019, closing a stake of 77,755 shares — an estimated $1.25M sold.

Raymond James & Associates first reported a position in MSF in Q2 2015 and held it in 13 quarters. The position peaked at $1.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds MSF as of Q1 2019.

  • Raymond James & Associates reported no remaining Morgan Stanley Emerging Mkts Fd position as of Q1 2019 after selling out during the quarter.
  • Raymond James & Associates sold 77,755 Morgan Stanley Emerging Mkts Fd shares in Q1 2019, an estimated $1.25M.
  • Raymond James & Associates first reported a position in Morgan Stanley Emerging Mkts Fd in Q2 2015 and held it in 13 quarters.
  • Raymond James & Associates's Morgan Stanley Emerging Mkts Fd position peaked at $1.3M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Morgan Stanley Emerging Mkts Fd as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.